Do you think you've discovered an error in this book?
Please check the list of errata below to see if we've already addressed the error.
If not, please submit the error via our
Errata Form.
We will attempt to verify your error; if you're right, we will post a correction below.
Chapter | Page | Details | Date | Print Run |
17 |
107 |
Errata
Table 17.4 Recommendations for starting antiretroviral therapy in adults. |
Presentation/ clinical condition |
BHIVA guidelines, Oct 2008 |
USDHHS, Dec 2009 |
Primary HIV infection |
Treatment in clinical trial
or neurological involvement
or CD4 <200 cells/mm3
>3/12
or AIDS-defining illness |
Treat |
Established HIV
infection: |
|
|
CD4 <200 cells/mm3 |
Treat |
Treat |
CD4 201-350
cells/mm3 |
Treat as soon as possible
when patient ready |
Treat |
CD4 351-500
cells/mm3 |
Treat in specific situations
when high risk of clinical
events, e.g. HIVAN,
hepatitis B co-infection
when HBV treatment
indicated |
Treatment optional |
CD4 >500 cells/mm3 |
Consider enrolment into
‘when to start trial’ |
Treat if HIVAN or HBV
co-infection when
HBV treatment
indicated |
AIDS diagnosis |
Treat (except for TB when
CD4 >350 cells/mm3) |
Treat |
BHIVA - British HIV Association Guidelines, USDHHS - United States
Department of Health and Human Services |
|
|
|